Literature DB >> 33266052

RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features.

Livia Archibugi1,2, Veronica Ruta3,4, Valentina Panzeri3,4, Miriam Redegalli2,5, Sabrina Gloria Giulia Testoni1,2, Maria Chiara Petrone1,2, Gemma Rossi1, Massimo Falconi2,6, Michele Reni7, Claudio Doglioni2,5, Claudio Sette3, Paolo Giorgio Arcidiacono1,2, Gabriele Capurso1,2.   

Abstract

Transcriptome analyses allow the distinguishing of pancreatic ductal adenocarcinoma (PDAC) subtypes, exhibiting different prognoses and chemotherapy responses. However, RNA extraction from pancreatic tissue is cumbersome and has been performed mainly from surgical samples, which are representative of < 20% of cases. The majority of PDAC patients undergo endoscopic ultrasound (EUS)-guided tissue acquisition (EUS-TA), but RNA has been rarely extracted from EUS-TA with scanty results. Herein, we aimed to determine the best conditions for RNA extraction and analysis from PDAC EUS-TA samples in order to carry out molecular analyses. PDAC cases underwent diagnostic EUS-TA, with needles being a 25G fine needle aspiration (FNA) in all patients and then either a 20G lateral core-trap fine needle biopsy (FNB) or a 25G Franseen FNB; the conservation methods were either snap freezing, RNALater or Trizol. RNA concentration and quality (RNA integrity index; RIN) were analyzed and a panel of genes was investigated for tissue contamination and markers of molecular subtype and aggressivity through qRT-PCR. Seventy-four samples from 37 patients were collected. The median RNA concentration was significantly higher in Trizol samples (10.33 ng/uL) compared with snap frozen (0.64 ng/uL; p < 0.0001) and RNALater (0.19 ng/uL; p < 0.0001). The RIN was similar between Trizol (5.15) and snap frozen samples (5.85), while for both methods it was higher compared with RNALater (2.7). Among the needles, no substantial difference was seen in terms of RNA concentration and quality. qRT-PCR analyses revealed that samples from all needles were suitable for the detection of PDAC subtype markers (GATA6 and ZEB1) and splice variants associated with mutational status (GAP17) as well as for the detection of contaminating tissue around PDAC cells. This is the first study that specifically investigates the best methodology for RNA extraction from EUS-TA. A higher amount of good quality RNA is obtainable with conservation in Trizol with a clear superiority of neither FNA nor FNB needles. RNA samples from EUS-TA are suitable for transcriptome analysis including the investigation of molecular subtype and splice variants expression.

Entities:  

Keywords:  EUS; FNA; FNB; RNA; extraction; molecular subtypes; optimization; pancreatic cancer

Mesh:

Substances:

Year:  2020        PMID: 33266052      PMCID: PMC7761443          DOI: 10.3390/cells9122561

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  35 in total

1.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

2.  NCCN Guidelines Updates: Pancreatic Cancer.

Authors:  Margaret A Tempero
Journal:  J Natl Compr Canc Netw       Date:  2019-05-01       Impact factor: 11.908

3.  Endoscopic ultrasound guided fine needle biopsy samples to drive personalized medicine: A proof of concept study.

Authors:  Alberto Larghi; Rita T Lawlor; Stefano Francesco Crinò; Claudio Luchini; Gianenrico Rizzatti; Mariangela Curatolo; Armando Gabbrielli; Frediano Inzani; Aldo Scarpa
Journal:  Pancreatology       Date:  2020-03-17       Impact factor: 3.996

4.  Basal-like and classical cells coexist in pancreatic cancer revealed by single-cell analysis on biopsy-derived pancreatic cancer organoids from the classical subtype.

Authors:  Natalia Juiz; Abdessamad Elkaoutari; Martin Bigonnet; Odile Gayet; Julie Roques; Rémy Nicolle; Juan Iovanna; Nelson Dusetti
Journal:  FASEB J       Date:  2020-07-20       Impact factor: 5.191

5.  EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6.

Authors:  Shilpa Patil; Benjamin Steuber; Waltraut Kopp; Vijayalakshmi Kari; Laura Urbach; Xin Wang; Stefan Küffer; Hanibal Bohnenberger; Dimitra Spyropoulou; Zhe Zhang; Lennart Versemann; Mark Sebastian Bösherz; Marius Brunner; Jochen Gaedcke; Philipp Ströbel; Jin-San Zhang; Albrecht Neesse; Volker Ellenrieder; Shiv K Singh; Steven A Johnsen; Elisabeth Hessmann
Journal:  Cancer Res       Date:  2020-09-09       Impact factor: 12.701

6.  Endoscopic ultrasound may be used to deliver gene expression signatures using digital mRNA detection methods to immunophenotype pancreatic ductal adenocarcinoma to facilitate personalized immunotherapy.

Authors:  Ferga C Gleeson; Michael J Levy; Rory A Jackson; Stephen J Murphy; Kevin C Halling; Benjamin R Kipp; Rondell P Graham; Lizhi Zhang
Journal:  Pancreatology       Date:  2019-12-05       Impact factor: 3.996

7.  ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.

Authors:  Mingyang Liu; Yuqing Zhang; Jingxuan Yang; Xiaobo Cui; Zhijun Zhou; Hanxiang Zhan; Kai Ding; Xiang Tian; Zhibo Yang; Kar-Ming A Fung; Barish H Edil; Russell G Postier; Michael S Bronze; Martin E Fernandez-Zapico; Marc P Stemmler; Thomas Brabletz; Yi-Ping Li; Courtney W Houchen; Min Li
Journal:  Gastroenterology       Date:  2019-11-09       Impact factor: 22.682

8.  Comparing Needles and Methods of Endoscopic Ultrasound-Guided Fine-Needle Biopsy to Optimize Specimen Quality and Diagnostic Accuracy for Patients With Pancreatic Masses in a Randomized Trial.

Authors:  Ji Young Bang; Konrad Krall; Nirag Jhala; Charanjeet Singh; Mohamedtaki Tejani; Juan Pablo Arnoletti; Udayakumar Navaneethan; Robert Hawes; Shyam Varadarajulu
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-08       Impact factor: 11.382

9.  Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Authors:  Talia Golan; Pascal Hammel; Michele Reni; Eric Van Cutsem; Teresa Macarulla; Michael J Hall; Joon-Oh Park; Daniel Hochhauser; Dirk Arnold; Do-Youn Oh; Anke Reinacher-Schick; Giampaolo Tortora; Hana Algül; Eileen M O'Reilly; David McGuinness; Karen Y Cui; Katia Schlienger; Gershon Y Locker; Hedy L Kindler
Journal:  N Engl J Med       Date:  2019-06-02       Impact factor: 91.245

10.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.

Authors:  Richard A Moffitt; Raoud Marayati; Elizabeth L Flate; Keith E Volmar; S Gabriela Herrera Loeza; Katherine A Hoadley; Naim U Rashid; Lindsay A Williams; Samuel C Eaton; Alexander H Chung; Jadwiga K Smyla; Judy M Anderson; Hong Jin Kim; David J Bentrem; Mark S Talamonti; Christine A Iacobuzio-Donahue; Michael A Hollingsworth; Jen Jen Yeh
Journal:  Nat Genet       Date:  2015-09-07       Impact factor: 38.330

View more
  4 in total

1.  Association of Matrix Metalloproteinase 7 Expression With Pathologic Response After Neoadjuvant Treatment in Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Sami Shoucair; Jianan Chen; James R Martinson; Joseph R Habib; Benedict Kinny-Köster; Ning Pu; A Floortje van Oosten; Ammar A Javed; Eun Ji Shin; Syed Z Ali; Kelly J Lafaro; Christopher L Wolfgang; Jin He; Jun Yu
Journal:  JAMA Surg       Date:  2022-07-13       Impact factor: 16.681

2.  Patient Reported Experience Measure in Endoscopic Ultrasonography: The PREUS Study Protocol.

Authors:  Laura Apadula; Gabriele Capurso; Alessandro Ambrosi; Paolo Giorgio Arcidiacono
Journal:  Nurs Rep       Date:  2022-02-08

3.  Accuracy and clinical outcomes of pancreatic EUS-guided fine-needle biopsy in a consecutive series of 852 specimens.

Authors:  Mikkel Marschall Thomsen; Michael Hareskov Larsen; Tina Di Caterino; Gitte Hedegaard Jensen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  Endosc Ultrasound       Date:  2022-06-08       Impact factor: 5.275

Review 4.  Endoscopic Ultrasound-Guided Sampling for Personalized Pancreatic Cancer Treatment.

Authors:  Eisuke Iwasaki; Seiichiro Fukuhara; Masayasu Horibe; Shintaro Kawasaki; Takashi Seino; Yoichi Takimoto; Hiroki Tamagawa; Yujiro Machida; Atsuto Kayashima; Marin Noda; Hideyuki Hayashi; Takanori Kanai
Journal:  Diagnostics (Basel)       Date:  2021-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.